Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An olmsted county study, 1976-1995

American Journal of Hematology

Volumn 61, Issue 1, 1999, Pages 10-15

  Mesa, Ruben A ^a   Silverstein, Murray N ^a   Jacobsen, Steven J ^a   Wollan, Peter C ^a   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

Author keywords

Agnogenic myeloid metaplasia; Epidemiology; Essential thrombocythemia; Outcome; Prognosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEMATOCRIT; HUMAN; INCIDENCE; MALE; MYELOID METAPLASIA; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; STEM CELL; SURVIVAL RATE; THROMBOCYTHEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; MYELOID METAPLASIA; PROGNOSIS; SURVIVAL RATE; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 0032916213     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I     Document Type: Article

References (19)

1. Chistolini A, Mazzucconi MG, Ferrari A, la Verde G, Ferrazza G, Dragoni F, Vitale A, Arcieri R, Mandelli F. Essential thrombocythemia: a retrospective study on the clinical course of 100 patients. Haematologica 1990;75:537.
2. Tefferi A, Silverstein MN, Hoagland HC. Primary thrombocythemia. Semin Oncol 1995;22:334.
3. Tefferi A, Silverstein MN, Noel P. Agnogenic myeloid metaplasia. Semin Oncol 1995:22:327.
4. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MN. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J Am Med Assoc 1993;270:860.
5. Ania BJ, Suman VJ, Sobell JL, Codd MB, Silverstein MN, Melton LJ III. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989. Am J Hematol 1994;47:89.
6. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266.
7. Bergstralh EJ, Offord KP, Chu CP, Beard CM, O'Fallon WM, Melton LJ. Calculating incidence and mortality rates for Olmsted County, Minnesota residents: an update. Rochester, Minnesota: Section of Biostatistics, Mayo Clinic; April 1992. Technical Report Series No. 49.
8. Therneau T, Sicks J, Bergstralh EJ, Offord KP. Expected survival based on hazard rates. Rochester, Minnesota: Section of Biostatistics, Mayo Clinic; March 1994. Technical Report Series No. 51.
9. Fleming TR, Harrington DP. A class of hypothesis tests for one- and two-sample censored survival data. Communications in Statistics; 1981. A10 (no. 8):763.
10. Bellucci S, Janvier M, Tobelem G, Flandrin G, Charpak Y, Berger R, Boiron M. Essential thrombocythemias. Clinical evolutionary and biological data. Cancer 1986;58:2440.
11. Hehlmann R, Jahn M, Baumann B, Kopcke W. Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 1988; 61:2487.
12. Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F. Clinical course of essential thrombocythemia in 147 cases. Cancer 1990;66:549.
13. Rozman C, Giralt M, Feliu E, Rubio D, Cortes MT. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991;67:2658.
14. Rupoli S, Da Lio L, Sisti S, Campanati G, Salvi A, Brianzoni MF, D'Amico S, Cinciripini A, Leoni P. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Ann Hematol 1994;68:205.
15. Dupriez B, Morel P, Demory JL, Lai JL, Simon M, Plantier I, Bauters F. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 1996;88:1013.
16. Cervantes F, Pereira A, Esteve J, Rafel M, Cobo F, Rozman C, Montserrat E. Identification of "short-lived" and "long-lived" patients at presentation of idiopathic myelofibrosis. Br J Haematol 1997;97:635.
17. Mughal TI: Primary thrombocythemia: a current perspective. Stem Cells 1995;13:355.
18. Randi ML, Fabris F, Rossi C, Tison T, Barbone E, Girolami A. Sex and age as prognostic factors in essential thrombocythemia. Haematologica 1992;77:402.
19. Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med 1995; 123:656.